Basic information Safety Supplier Related

(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE

Basic information Safety Supplier Related

(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE Basic information

Product Name:
(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE
Synonyms:
  • (S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE
  • (S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-PROPANAMINE
  • (S)-α-Methyl-3-(trifluoromethyl)benzeneethanamine
  • [S,(+)]-α-Methyl-3-(trifluoromethyl)benzeneethanamine
  • [S,(+)]-α-Methyl-m-(trifluoromethyl)phenethylamine
  • Dexnorfenfluramine
  • Nordexfenfluramine
  • Einecs 242-769-7
CAS:
19036-73-8
MF:
C10H12F3N
MW:
203.2
EINECS:
2427697
Mol File:
19036-73-8.mol
More
Less

(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE Chemical Properties

storage temp. 
4°C, protect from light
form 
Liquid
color 
Colorless to light yellow
More
Less

(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANE Usage And Synthesis

Uses

(+)-Norfenfluramine a major hepatic metabolite of (+)-fenfluramine, is a selective 5-HT2B receptor agonist (Ki: 11.2 nM). (+)-Norfenfluramine potently stimulates the hydrolysis of inositol phosphates and increases intracellular Ca2+. (+)-Norfenfluramine can be used for the research of primary pulmonary hypertension and valvular heart disease[1].

Definition

ChEBI: (2S)-1-[3-(trifluoromethyl)phenyl]-2-propanamine is a member of amphetamines.

in vivo

(+)-Norfenfluramine (1-300 μg/kg, i.v.) induces pressor response in conscious SHAM and DOCA-salt rats[1].
(+)-Norfenfluramine (2.5 and 5 mg/kg, i.p.) decreases of 5-HT and 5-HIAA levels in telencephalon and brainstem of rats[3].

Animal Model:Conscious SHAM and DOCA-salt rats[1].
Dosage:1-300 μg/kg
Administration:Intravenous injection (i.v.), given in a cumulative fashion at 6-min intervals.
Result:Induced pressor response in conscious SHAM and DOCA-salt rats. (change in mean arterial blood pressure at 300 μg/kg, mm Hg, SHAM vehicle=36, SHAM ketanserin=7, DOCA=51, DOCA ketanserin=19).

IC 50

5-HT2B Receptor: 11.2 nM (Ki); 5-HT2A Receptor: 1516 nM (Ki); 5-HT2C Receptor: 324 nM (Ki)

References

[1] Wei Ni, et al. The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension. J Pharmacol Exp Ther. 2007 May;321(2):485-91. DOI:10.1124/jpet.106.114017
[2] M Gobbi, et al. In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool. Naunyn Schmiedebergs Arch Pharmacol. 1998 Sep;358(3):323-7. DOI:10.1007/pl00005260
[3] R Invernizzi, et al. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain? Br J Pharmacol. 1982 Mar;75(3):525-30. DOI:10.1111/j.1476-5381.1982.tb09169.x

(S)-1-(3-TRIFLUOROMETHYLPHENYL)-2-AMINOPROPANESupplier

Amadis Chemical Company Limited
Tel
571-89925085
Email
sales@amadischem.com
Mirro Chemical Co.,Ltd.
Tel
0086-15313090952
Kanghua (Shanghai) New Drug Development Co., Ltd.
Tel
021-61263370 18901917034
Email
xingli@glbiochem.com
Shanghai Jifeng Biotechnology Co., Ltd.
Tel
021-61263377 15023907684
Email
15800684150@163.com
GL Biochem (Shanghai) Ltd.
Tel
+86-021-61263370 +86-18901917034